alk-001
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2014 (NCT02230228)
Timeline
Indications
Mechanism of action
STRA6 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- alk-001
- alk-001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04239625 | Phase 2 | Dec 20, 2019 | Alkeus Pharmaceuticals, Inc. |
| NCT03845582 | Phase 3 | May 7, 2019 | Alkeus Pharmaceuticals, Inc. |
| NCT02402660 | Phase 2 | Aug 1, 2015 | Alkeus Pharmaceuticals, Inc., University of Basel |
| NCT02230228 | Phase 1 | Apr 1, 2014 | Alkeus Pharmaceuticals, Inc., Columbia University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alkeus Pharmaceuticals, Inc. | For profit | 4 | 4 | 3 | 2014 |
| Columbia University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Basel | Academic/Hospital | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1